PortfoliosLab logoPortfoliosLab logo
GMED vs. DLO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GMED vs. DLO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Globus Medical, Inc. (GMED) and DLocal Limited (DLO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GMED achieves a -10.54% return, which is significantly lower than DLO's 9.23% return.


GMED

1D
1.92%
1M
-2.99%
6M
-17.32%
YTD
-10.54%
1Y
36.75%
3Y*
8.91%
5Y*
-0.63%
10Y*
12.07%

DLO

1D
4.26%
1M
23.10%
6M
7.78%
YTD
9.23%
1Y
40.67%
3Y*
7.48%
5Y*
-20.08%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GMED vs. DLO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GMED
Globus Medical, Inc.
-10.54%5.56%55.21%-28.25%2.87%2.32%
DLO
DLocal Limited
9.23%31.72%-36.35%13.62%-56.37%15.13%

Correlation

The correlation between GMED and DLO is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Jun 3, 2021

0.33

Fundamentals

Market Cap

GMED:

$10.53B

DLO:

$4.46B

EPS

GMED:

$4.28

DLO:

$0.64

PE Ratio

GMED:

18.23

DLO:

23.71

PEG Ratio

GMED:

0.19

DLO:

0.74

PS Ratio

GMED:

3.45

DLO:

3.76

PB Ratio

GMED:

2.28

DLO:

8.23

Total Revenue (TTM)

GMED:

$3.10B

DLO:

$1.21B

Gross Profit (TTM)

GMED:

$1.58B

DLO:

$436.56M

EBITDA (TTM)

GMED:

$803.34M

DLO:

$280.42M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GMED vs. DLO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMED
GMED Risk / Return Rank: 7373
Overall Rank
GMED Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 7575
Sortino Ratio Rank
GMED Omega Ratio Rank: 7272
Omega Ratio Rank
GMED Calmar Ratio Rank: 7575
Calmar Ratio Rank
GMED Martin Ratio Rank: 7575
Martin Ratio Rank

DLO
DLO Risk / Return Rank: 6868
Overall Rank
DLO Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
DLO Sortino Ratio Rank: 6868
Sortino Ratio Rank
DLO Omega Ratio Rank: 6767
Omega Ratio Rank
DLO Calmar Ratio Rank: 6969
Calmar Ratio Rank
DLO Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GMED vs. DLO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and DLocal Limited (DLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GMEDDLODifference
Sharpe ratioReturn per unit of total volatility

+0.08

Sortino ratioReturn per unit of downside risk

+0.36

Omega ratioGain probability vs. loss probability

1.21

1.17

+0.03

Calmar ratioReturn relative to maximum drawdown

1.60

1.17

+0.43

Martin ratioReturn relative to average drawdown

3.87

2.33

+1.54

GMED vs. DLO - Sharpe Ratio Comparison

The current GMED Sharpe Ratio is 0.71, which is comparable to the DLO Sharpe Ratio of 0.64. The chart below compares the historical Sharpe Ratios of GMED and DLO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GMED vs. DLO - Drawdown Comparison

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum DLO drawdown of -89.99%. Use the drawdown chart below to compare losses from any high point for GMED and DLO.


Loading charts...

Drawdown Indicators


GMEDDLODifference

Max Drawdown

Largest peak-to-trough decline

-47.91%

-89.99%

+42.08%

Max Drawdown (1Y)

Largest decline over 1 year

-22.10%

-30.45%

+8.35%

Max Drawdown (3Y)

Largest decline over 3 years

-44.40%

-68.59%

+24.19%

Max Drawdown (5Y)

Largest decline over 5 years

-47.91%

-89.99%

+42.08%

Max Drawdown (10Y)

Largest decline over 10 years

-47.91%

Current Drawdown

Current decline from peak

-19.32%

-76.52%

+57.20%

Average Drawdown

Average peak-to-trough decline

-15.33%

-70.30%

+54.97%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.13%

15.34%

-6.21%

Volatility

GMED vs. DLO - Volatility Comparison

The current volatility for Globus Medical, Inc. (GMED) is 13.69%, while DLocal Limited (DLO) has a volatility of 15.39%. This indicates that GMED experiences smaller price fluctuations and is considered to be less risky than DLO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GMEDDLODifference

Volatility (1M)

Calculated over the trailing 1-month period

13.69%

15.39%

-1.70%

Volatility (6M)

Calculated over the trailing 6-month period

25.33%

36.05%

-10.72%

Volatility (1Y)

Calculated over the trailing 1-year period

49.46%

56.14%

-6.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.27%

73.39%

-35.12%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.68%

73.52%

-37.84%

Dividends

GMED vs. DLO - Dividend Comparison

GMED has not paid dividends to shareholders, while DLO's dividend yield for the trailing twelve months is around 1.28%.


PositionTTM2025
DLO
DLocal Limited
1.28%3.71%
GMED
Globus Medical, Inc.
0.00%0.00%

Financials

GMED vs. DLO - Financials Comparison

This section allows you to compare key financial metrics between Globus Medical, Inc. and DLocal Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
759.85M
335.86M
(GMED) Total Revenue
(DLO) Total Revenue
Values in USD except per share items

GMED vs. DLO - Profitability Comparison

The chart below illustrates the profitability comparison between Globus Medical, Inc. and DLocal Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
35.3%
Portfolio components
GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

DLO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, DLocal Limited reported a gross profit of 118.68M and revenue of 335.86M. Therefore, the gross margin over that period was 35.3%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

DLO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, DLocal Limited reported an operating income of 53.55M and revenue of 335.86M, resulting in an operating margin of 15.9%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.

DLO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, DLocal Limited reported a net income of 41.98M and revenue of 335.86M, resulting in a net margin of 12.5%.


Frequently Asked Questions


GMED and DLO have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DLO has higher volatility (15.39%) compared to GMED (13.69%). In terms of maximum drawdown, GMED dropped -47.91% vs DLO's -89.99%.

GMED currently has the higher Sharpe Ratio (0.71 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GMED and DLO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer